Integer Holdings Co. (NYSE:ITGR) Receives Consensus Rating of “Moderate Buy” from Analysts

Integer Holdings Co. (NYSE:ITGR) has received a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $139.75.

A number of research analysts have recently weighed in on the company. Truist Financial lowered their price objective on Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Piper Sandler reissued an “overweight” rating and issued a $140.00 price target (up from $125.00) on shares of Integer in a report on Friday, October 25th. Oppenheimer initiated coverage on Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target on the stock. KeyCorp boosted their price target on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a report on Tuesday, October 15th. Finally, Benchmark boosted their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st.

Integer Trading Up 5.2 %

Integer stock opened at $135.42 on Thursday. The business has a 50-day simple moving average of $128.18 and a two-hundred day simple moving average of $121.62. The company has a market cap of $4.54 billion, a P/E ratio of 41.80, a P/E/G ratio of 1.82 and a beta of 1.09. Integer has a 52-week low of $83.69 and a 52-week high of $136.07. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. During the same period in the previous year, the company posted $1.27 EPS. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. Analysts predict that Integer will post 5.33 EPS for the current year.

Hedge Funds Weigh In On Integer

Large investors have recently modified their holdings of the stock. GSA Capital Partners LLP bought a new position in shares of Integer during the 1st quarter valued at approximately $786,000. Blue Trust Inc. increased its position in shares of Integer by 460.4% during the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock valued at $658,000 after purchasing an additional 4,636 shares during the last quarter. UniSuper Management Pty Ltd bought a new position in Integer in the 1st quarter valued at $976,000. Earnest Partners LLC grew its position in Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after acquiring an additional 37,340 shares during the last quarter. Finally, Great Lakes Advisors LLC grew its position in Integer by 56.7% in the 2nd quarter. Great Lakes Advisors LLC now owns 45,218 shares of the medical equipment provider’s stock valued at $5,236,000 after acquiring an additional 16,355 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.